Great! You have sucessfully subscribed for newsletters for investments
Subscribed email:
NAV as of Jul 21, 2025 | Returns since inception | ET Money Rank | AUM (Fund size) |
---|---|---|---|
₹9.969-0.36% 1 day change | -1.11% | ₹321 Cr |
Expense ratio | 0.67% as on May 31, 2025 |
Exit load | 1.0% 1% for redemption within 3 Months! |
AUM (Fund size) | ₹321 Cr |
Lock-in Period | Nil |
Age | 7 m since Dec 06, 2024 |
Benchmark | BSE Healthcare TRI |
Min. investment | SIP: ₹500 & Lumpsum: ₹1000 |
Risk | Very High |
Short term capital gains (STCG) | Returns taxed at 20% if you redeem before 1 year |
Long term capital gains (LTCG) | After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5% |
Period | This fund | Category average |
---|---|---|
1 Month | 3.55% | 3.63% |
3 Months | 6.44% | 6.89% |
6 Months | 3.56% | 5.47% |
Large Cap 31.41%
Mid Cap 31.25%
Small Cap 32.84%
Other Cap 0%
Healthcare 84.84%
Consumer Staples 6.82%
Services 1.79%
Materials 1.56%
Bifurcation by Credit Quality is not available for this fund
Bifurcation by Holding is not available for this fund
Net Receivables 4.5%
Others 4.5%
Fund name | ETM Rank | AUM | Fund age | Expense ratio |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund | N.A. | 321 Cr | 7 m | 0.67% |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | N.A. | 5,295 Cr | 7 yrs 1 m | 1.06% |
SBI Healthcare Opportunities Fund | N.A. | 3,671 Cr | 12 yrs 6 m | 0.9% |
DSP Healthcare Fund | N.A. | 2,961 Cr | 6 yrs 8 m | 0.62% |
Tata India Pharma & HealthCare Fund | N.A. | 1,232 Cr | 9 yrs 7 m | 0.63% |
Mirae Asset Healthcare Fund | N.A. | 2,691 Cr | 7 yrs 1 m | 0.5% |
Fund name | 1M | 6M | 1Y | 3Y | 5Y | 10Y |
---|---|---|---|---|---|---|
Bajaj Finserv Healthcare Fund | 3.55% | 3.56% | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 4.09% | 7.52% | 21.23% | 30.15% | 25.59% | 16.02% |
SBI Healthcare Opportunities Fund | 3.05% | 6.19% | 21.0% | 29.45% | 25.4% | 13.03% |
DSP Healthcare Fund | 4.09% | 0.19% | 14.3% | 27.12% | 24.42% | 15.94% |
Tata India Pharma & HealthCare Fund | 3.06% | 3.68% | 13.15% | 25.54% | 23.75% | 13.51% |
Mirae Asset Healthcare Fund | 4.78% | 7.03% | 16.41% | 25.1% | 24.13% | 15.97% |
Fund name | Std. deviation | Beta | Sharpe | Sortino |
---|---|---|---|---|
Bajaj Finserv Healthcare Fund | N.A. | N.A. | N.A. | N.A. |
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund | 15.37 | 0.94 | 1.44 | 2.04 |
SBI Healthcare Opportunities Fund | 13.71 | 0.84 | 1.58 | 2.27 |
DSP Healthcare Fund | 14.68 | 0.85 | 1.35 | 2.22 |
Tata India Pharma & HealthCare Fund | 15.95 | 0.99 | 1.2 | 1.83 |
Mirae Asset Healthcare Fund | 16.24 | 1.0 | 1.11 | 1.76 |
Risk ratios are based on three-year data. The required data is unavailable for the scheme.
Fund AUM | 321 Cr as on May 31, 2025 |
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
No. of schemes | 13 view all schemes |
Total AUM | 24,110 Cr as on Jun 30, 2025 |
Address | 8th floor, E-Core, Solitaire Business Hub (formerly Marvel Edge), Viman Nagar Pune , 411014 |
Phone | 1800-309-3900 |
Fund name | ETM Rank | AUM | 1Y | 5Y |
---|---|---|---|---|
Bajaj Finserv Flexi Cap Fund | N.A. | 4,850 Cr | 9.25% | N.A. |
Bajaj Finserv ELSS Tax Saver Fund | N.A. | 56 Cr | N.A. | N.A. |
Bajaj Finserv Large Cap Fund | N.A. | 1,496 Cr | N.A. | N.A. |
Bajaj Finserv Consumption Fund | N.A. | 571 Cr | N.A. | N.A. |
The current Net Asset Value (NAV) of the Bajaj Finserv Healthcare Fund - Direct Growth plan is approximately ₹9.969 as of Jul 21, 2025.
The Bajaj Finserv Healthcare Fund - Direct Growth has an expense ratio of 0.67%, which reflects the fund's management and operating costs. This percentage is subtracted from the fund's annual returns, impacting net returns for investors.
The Bajaj Finserv Healthcare Fund currently has assets under management (AUM) or fund size valued at approximately 321 Cr as on May 31, 2025.
The Bajaj Finserv Healthcare Fund has invested the majority of its money in the stocks of the following companies -
Company | Percentage of Portfolio |
---|---|
Divi's Laboratories Ltd. | 8.71% |
Sun Pharmaceutical Industries Ltd. | 7.82% |
Cipla Ltd. | 6.61% |
Apollo Hospitals Enterprise Ltd. | 5.86% |
Dr. Reddy's Laboratories Ltd. | 3.52% |
Piramal Pharma Ltd. | 3.5% |
Biocon Ltd. | 3.43% |
Emcure Pharmaceuticals Ltd. | 3.4% |
Glenmark Pharmaceuticals Ltd. | 2.81% |
Neuland Laboratories Ltd. | 2.76% |
The Bajaj Finserv Healthcare Fund has primarily invested in the following sectors
Sector | Percentage of Portfolio |
---|---|
Healthcare | 84.84% |
Consumer Staples | 6.82% |
Services | 1.79% |
Materials | 1.56% |
Chemicals | 0.49% |
This is a Sectoral-pharma fund comes with Very High risk.
No, this fund does not have any lock-in period.
It is very fast, easy, and completely paperless in this mutual fund scheme on ET Money. It is just a matter of a few minutes. Here's how:
For the Desktop Version:
For the Mobile Version:
All set! Your investment in Bajaj Finserv Healthcare Fund is complete.
Redeeming your investments in Bajaj Finserv Healthcare Fund is super easy. If you have invested in this fund via ET Money, just login into the app, go to the investment section and put the redemption request.
If you have invested in Bajaj Finserv Healthcare Fund from anywhere else, you can go to the fund house website and put a request through it.